As home of the Baylor College of Medicine Dan L Duncan Comprehensive Cancer Center at Baylor St. Luke’s Medical Center, CHI St. Luke’s Health is partnered with the largest clinical genetics program in the nation. This gives us the opportunity to analyze the genetic makeup of patients to identify the potential for cancer, take measures to prevent its onset, and develop custom treatments for each case. Our strong academic and research programs allow us to provide leading-edge cancer treatment to our patients.
This emergent research has led to impressive clinical applications. For example, specific gene changes can be used to predict which patients will have a better or worse outcome from treatment. This provides the oncology team with greater insight when planning the intensity of each patient’s treatment plan. Additionally, doctors can test for gene mutations in cancer cells that could indicate certain medications would be ineffective.
The experts at CHI St. Luke’s Health can provide guidance about gene therapy options specific for each patient. If you have questions about gene therapy or oncology treatments, ask your physician for more information about what’s right for you.